
Jeffrey H. Murray
Examiner (ID: 2022, Phone: (571)272-9023 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1699, 1609 |
| Total Applications | 1761 |
| Issued Applications | 1272 |
| Pending Applications | 9 |
| Abandoned Applications | 485 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5046598
[patent_doc_number] => 20070265272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'TRIAZOLOPYRAZINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/745921
[patent_app_country] => US
[patent_app_date] => 2007-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54213
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265272.pdf
[firstpage_image] =>[orig_patent_app_number] => 11745921
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/745921 | Triazolopyrazine derivatives | May 7, 2007 | Issued |
Array
(
[id] => 4644601
[patent_doc_number] => 08022207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Compound having affinity to amyloid'
[patent_app_type] => utility
[patent_app_number] => 12/226561
[patent_app_country] => US
[patent_app_date] => 2007-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 15
[patent_no_of_words] => 17309
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022207.pdf
[firstpage_image] =>[orig_patent_app_number] => 12226561
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226561 | Compound having affinity to amyloid | Apr 25, 2007 | Issued |
Array
(
[id] => 5016695
[patent_doc_number] => 20070259904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Bi-aryl meta-pyrimidine inhibitors of kinases'
[patent_app_type] => utility
[patent_app_number] => 11/796717
[patent_app_country] => US
[patent_app_date] => 2007-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 71093
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259904.pdf
[firstpage_image] =>[orig_patent_app_number] => 11796717
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/796717 | Bi-aryl meta-pyrimidine inhibitors of kinases | Apr 25, 2007 | Issued |
Array
(
[id] => 5016686
[patent_doc_number] => 20070259895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'MGluR5 modulators VI'
[patent_app_type] => utility
[patent_app_number] => 11/790424
[patent_app_country] => US
[patent_app_date] => 2007-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10745
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11790424
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/790424 | MGluR5 modulators VI | Apr 24, 2007 | Abandoned |
Array
(
[id] => 5016651
[patent_doc_number] => 20070259860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'MGluR5 modulators V'
[patent_app_type] => utility
[patent_app_number] => 11/790429
[patent_app_country] => US
[patent_app_date] => 2007-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24254
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259860.pdf
[firstpage_image] =>[orig_patent_app_number] => 11790429
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/790429 | MGluR5 modulators V | Apr 24, 2007 | Abandoned |
Array
(
[id] => 5126471
[patent_doc_number] => 20070238742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'METHODS OF PREPARATION AND RESOLUTION OF E/Z ISOMERS OF VINYLFURO[2,3-D]PYRIMIDINE AND THEIR BIOLOGICAL ACTIVITIES AND RELATED COMPOSITIONS AND METHODS OF TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 11/734831
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7757
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238742.pdf
[firstpage_image] =>[orig_patent_app_number] => 11734831
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/734831 | METHODS OF PREPARATION AND RESOLUTION OF E/Z ISOMERS OF VINYLFURO[2,3-D]PYRIMIDINE AND THEIR BIOLOGICAL ACTIVITIES AND RELATED COMPOSITIONS AND METHODS OF TREATMENT | Apr 12, 2007 | Abandoned |
Array
(
[id] => 4753236
[patent_doc_number] => 20080161311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/783270
[patent_app_country] => US
[patent_app_date] => 2007-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86117
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161311.pdf
[firstpage_image] =>[orig_patent_app_number] => 11783270
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/783270 | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor | Apr 5, 2007 | Abandoned |
Array
(
[id] => 5398416
[patent_doc_number] => 20090318479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'SUBSTITUTED RING FUSED AZINES AND THEIR USE IN CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/296377
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38461
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318479.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296377
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296377 | SUBSTITUTED RING FUSED AZINES AND THEIR USE IN CANCER THERAPY | Apr 3, 2007 | Abandoned |
Array
(
[id] => 5285542
[patent_doc_number] => 20090099217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => '2-Aminopyrimidin-4-Ones And Their Use For Treating Or Preventing Alpha Beta-Related Pathologies'
[patent_app_type] => utility
[patent_app_number] => 12/295959
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15305
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12295959
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/295959 | 2-Aminopyrimidin-4-Ones And Their Use For Treating Or Preventing Alpha Beta-Related Pathologies | Apr 3, 2007 | Abandoned |
Array
(
[id] => 5046606
[patent_doc_number] => 20070265280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'METHODS OF USING SODIUM CHANNEL BLOCKERS'
[patent_app_type] => utility
[patent_app_number] => 11/695936
[patent_app_country] => US
[patent_app_date] => 2007-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34327
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265280.pdf
[firstpage_image] =>[orig_patent_app_number] => 11695936
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/695936 | METHODS OF USING SODIUM CHANNEL BLOCKERS | Apr 2, 2007 | Abandoned |
Array
(
[id] => 5265592
[patent_doc_number] => 20090118277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => '3 Unsubstituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/296156
[patent_app_country] => US
[patent_app_date] => 2007-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20026
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118277.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296156
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296156 | 3 Unsubstituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase Inhibitors | Apr 1, 2007 | Abandoned |
Array
(
[id] => 5211017
[patent_doc_number] => 20070249601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'COMPOUNDS AND THERAPEUTICAL USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/693432
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 86422
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249601.pdf
[firstpage_image] =>[orig_patent_app_number] => 11693432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/693432 | COMPOUNDS AND THERAPEUTICAL USE THEREOF | Mar 28, 2007 | Abandoned |
Array
(
[id] => 92292
[patent_doc_number] => 07732454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Inhibitors of Bruton\'s tyrosine kinase'
[patent_app_type] => utility
[patent_app_number] => 11/692870
[patent_app_country] => US
[patent_app_date] => 2007-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 43257
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732454.pdf
[firstpage_image] =>[orig_patent_app_number] => 11692870
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/692870 | Inhibitors of Bruton's tyrosine kinase | Mar 27, 2007 | Issued |
Array
(
[id] => 5474388
[patent_doc_number] => 20090247554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/295124
[patent_app_country] => US
[patent_app_date] => 2007-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37281
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247554.pdf
[firstpage_image] =>[orig_patent_app_number] => 12295124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/295124 | KINASE INHIBITORS | Mar 26, 2007 | Abandoned |
Array
(
[id] => 4977986
[patent_doc_number] => 20070219219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Methods of Preparation and Resolution of E/Z Isomers of Vinylfuro[2,3-D]Pyrimidine and their Biological Activities and related compositions and methods of treatment'
[patent_app_type] => utility
[patent_app_number] => 11/687888
[patent_app_country] => US
[patent_app_date] => 2007-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2322
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219219.pdf
[firstpage_image] =>[orig_patent_app_number] => 11687888
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/687888 | Methods of Preparation and Resolution of E/Z Isomers of Vinylfuro[2,3-D]Pyrimidine and their Biological Activities and related compositions and methods of treatment | Mar 18, 2007 | Abandoned |
Array
(
[id] => 4977960
[patent_doc_number] => 20070219193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'ALKYLAMINE-SUBSTITUTED BICYCLIC ARYL COMPOUNDS USEFUL AS MODULATORS OF PPAR'
[patent_app_type] => utility
[patent_app_number] => 11/687485
[patent_app_country] => US
[patent_app_date] => 2007-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19356
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219193.pdf
[firstpage_image] =>[orig_patent_app_number] => 11687485
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/687485 | ALKYLAMINE-SUBSTITUTED BICYCLIC ARYL COMPOUNDS USEFUL AS MODULATORS OF PPAR | Mar 15, 2007 | Abandoned |
Array
(
[id] => 5063631
[patent_doc_number] => 20070225271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Pyrimidine, quinazoline, pteridine and triazine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/724688
[patent_app_country] => US
[patent_app_date] => 2007-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53020
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225271.pdf
[firstpage_image] =>[orig_patent_app_number] => 11724688
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/724688 | Pyrimidine, quinazoline, pteridine and triazine derivatives | Mar 14, 2007 | Issued |
Array
(
[id] => 4977950
[patent_doc_number] => 20070219183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Dihydropyrazolo[1,5-A]pyrimidine and dihydroimidazo[1,5-A]pyrimidine derivatives and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/724489
[patent_app_country] => US
[patent_app_date] => 2007-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11095
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11724489
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/724489 | Dihydropyrazolo[1,5-A]pyrimidine and dihydroimidazo[1,5-A]pyrimidine derivatives and methods of use thereof | Mar 14, 2007 | Abandoned |
Array
(
[id] => 5247880
[patent_doc_number] => 20070244114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'COMPOUNDS AND THERAPEUTICAL USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/685342
[patent_app_country] => US
[patent_app_date] => 2007-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 86403
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244114.pdf
[firstpage_image] =>[orig_patent_app_number] => 11685342
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/685342 | COMPOUNDS AND THERAPEUTICAL USE THEREOF | Mar 12, 2007 | Abandoned |
Array
(
[id] => 4599803
[patent_doc_number] => 07977342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-12
[patent_title] => 'HCV inhibiting bi-cyclic pyrimidines'
[patent_app_type] => utility
[patent_app_number] => 11/684288
[patent_app_country] => US
[patent_app_date] => 2007-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22643
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/977/07977342.pdf
[firstpage_image] =>[orig_patent_app_number] => 11684288
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/684288 | HCV inhibiting bi-cyclic pyrimidines | Mar 8, 2007 | Issued |